Genmab A/SGMABNASDAQ
Loading
Total Costs & Expenses Over TimeContracting
Percentile Rank86
3Y CAGR+6.1%
5Y CAGR+21.0%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
+6.1%/yr
vs +49.6%/yr prior
5Y CAGR
+21.0%/yr
Recent deceleration
Acceleration
-43.5pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
2.6x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$9.85B-33.6%
2024$14.82B+32.9%
2023$11.15B+35.4%
2022$8.24B+50.8%
2021$5.46B+43.9%
2020$3.80B+39.2%
2019$2.73B+65.9%
2018$1.64B+61.1%
2017$1.02B+33.8%
2016$763.29M-